Dietary Supplements Market Share, Size, Future Demand, and Emerging Trends The major drivers in the global dietary supplements market are paradigm shifts in consumer preferences, increasing prevalence of long-term disorders, rising consumer inclination toward physical well-being and health, and snowballing demand for sports nutritional supplements. In 2021, the market stood at $123.1 billion, and it is predicted to touch $288.5 billion by 2030. The market will witness an approximately 10% CAGR from 2021 to 2030. The growth in the market will go hand in hand with the surging consumer awareness toward a healthy lifestyle, and the rising count of gyms and sports complexes. Within the distribution channel segment, the development of the online retail category will augment growth in the dietary supplements market. There is a surging investment in the R&D activities to adapt to the shifting consumer tastes and preferences to cater to a wide range of consumers. Also, the increasing number of smartphones and rising internet penetration have boosted the sales of this category. Moreover, a surging inclination toward online retail will lead to an expansion of the scope of these products. Moreover, tailoring supplements for a specific consumer bracket will drive the market. Get More Insights: https://www.psmarketresearch.com/market-analysis/dietary-supplements-market In 2021, APAC dominated the dietary supplements market, accounting for at least 45% of the global market share. This can be ascribed to the surging awareness regarding supplements, growing population, increasing incidence of obesity, rising disposable income, and consequently, increasing purchasing parity of consumers on these health-enhancing products. Moreover, the market demand is fueled by the increasing incidence of chronic illness among the populous nations of Japan, India, and China. Hence, a growing geriatric population, coupled with a growing count of gyms, health clubs, and fitness centers.

Age-Related Macular Degeneration Therapeutics Pipeline Analysis Analysis by Trends, Size, Share, Growth Opportunities, and Emerging Technologies Age-related macular degeneration (AMD) is a progressive eye condition that impacts millions of individuals globally, mainly those aged 50 and more. It is one of the leading causes of vision loss and blindness, significantly impacting the quality of life for individuals. Over the years, extensive R&D efforts have been dedicated to finding effective therapeutics for AMD. In this article, we will explore the promising pipeline of treatments for AMD. Current Status of Wet AMD Medications Also known as advanced neovascular AMD, this eye illness is not that common, and it develops at a faster pace in comparison to dry AMD. However, even dry AMD can also turn into wet AMD. It occurs when abnormal blood vessels form in the back of the eye and harm the macula. But, the only good thing about wet AMD is that the cure for this illness is available. These days, only a limited number of medications to cure this illness are licensed, the most prominent of them being anti-VEGF agents. Such medicines require regular and uncomfortable intraocular injections, which stop the formation of this molecule, thus effectively stopping the formation of the excess blood vessels that damage vision. Browse detailed report - https://www.psmarketresearch.com/market-analysis/age-related-macular-degeneration-therapeutics-pipeline-analysis How Can You Lower Risk for AMD? According to research, you can be able to lower your risk of AMD (or slow vision loss from AMD) by following these healthy choices: • Don’t smoke • Regular physical exercise • Keep blood pressure and cholesterol in check • Eat healthy foods, such as leafy green vegetables and fish Hence, even though the therapeutics pipeline for age-related macular degeneration, particularly wet AMD, is quite promising, a healthy lifestyle can help you avoid this illness altogether.

Medical Supplies Market Revenue Poised for Significant Growth During the Forecast Period The global Medical Supplies Market is forecasted to be worth USD 180.89 Billion by 2027, according to a current analysis by Emergen Research. The growing incidence of chronic diseases due to unhealthy lifestyle habits is expected to drive the demand for medical supplies over the forecast period. Request Free Sample Copy @ https://www.emergenresearch.com/request-sample/380